immunity News and Research

RSS

Angiotensin-converting enzyme 2 allosteric binders found to be effective against SARS-CoV-2

Researchers reported a hybrid approach comprising computational models and high throughput screening to discover allosteric ACE2 binders inhibiting viral replication without interrupting ACE2 renal, pulmonary, immune, and cardiovascular functions.

22 Mar 2022

Waning antibody responses in SARS-CoV-2-infected or vaccinated population

A recent study posted to the bioRxiv* preprint server evaluated the effects of the waning of antibodies after coronavirus disease 2019 (COVID-19) infection or vaccination.

22 Mar 2022

Study: Ketogenic diet helps kill pancreatic cancer cells when combined with a triple-drug therapy

The findings of a new study suggest that a ketogenic diet - which is low in carbohydrates and protein, but high in fat - helps to kill pancreatic cancer cells when combined with a triple-drug therapy developed by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope.

22 Mar 2022

New research proves benefit of vaccination after recovery from COVID-19

When our immune system comes into contact with the SARS-CoV-2 coronavirus, it fights back and produces antibodies.

22 Mar 2022

SARS-CoV-2 infection risk among dialysis patients during Omicron surge

A recent study posted to the medRxiv* preprint server evaluated the antibody responses against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) patients receiving hemodialysis.

22 Mar 2022

Association between seropositivity and comorbidities after COVID-19 vaccination

In a recent study posted to the medRxiv* preprint server, researchers demonstrated that comorbidities attenuated the chance of seropositivity following coronavirus disease 2019 (COVID-19) vaccination.

22 Mar 2022

Is COVID-19 on the verge of ending?

Researchers explore the changes arising in SARS-CoV-2 over time.

21 Mar 2022

A circRNA COVID vaccine with potential to neutralize SARS-CoV-2 variants

Researchers demonstrate the broad neutralization potential of a strategically engineered circRNA using mice as a model system.

21 Mar 2022

SARS-CoV-2 transmitters have 3 times higher viral loads than non-transmitters

Researchers discuss the difference between transmitters and non-transmitters of SARS-CoV-2 in terms of their mean viral load.

21 Mar 2022

Mount Sinai launches phase 1 study to evaluate the safety, immunogenicity of egg-based COVID-19 vaccine

A team of clinical investigators at the Icahn School of Medicine at Mount Sinai has announced the launch of a Phase 1, open-label, placebo-controlled study to evaluate the safety and immunogenicity of an egg-based COVID-19 vaccine in healthy, vaccinated adults who have never been infected with COVID-19.

21 Mar 2022

Oral drug that reverses immune aging effectively prevents death in COVID-19 mouse model

The immune system deteriorates with age, making COVID-19 particularly deadly in older people - but to date, no clinically available medication addresses this key risk factor.

21 Mar 2022

Glycogen synthase kinase-3 inhibitors found to attenuate COVID-19-associated cytokine storm

In a new study, researchers investigated whether the SARS-CoV-2 spike protein and its S2 subunit induced the expression of C–X–C motif chemokine 10, a subset of cytokine.

21 Mar 2022

Clinical severity of SARS-CoV-2-Omicron infection found to be lower than Delta infection

Researchers evaluated the severity of SARS-CoV-2cc infection by the Omicron variant compared to the Delta variant.

21 Mar 2022

Study assesses human milk antibodies against common human coronaviruses following COVID-19 infection and vaccination

A recent study demonstrated that COVID-19 and its vaccination generates cross-reactive antibodies against human coronaviruses in lactating mothers.

21 Mar 2022

Sex-specific differences in T-cell responses to COVID-19

Researchers evaluate both neutralizing activity and T-cell responses in SARS-CoV-2 infected individuals with mild symptoms linked to a single spreading event.

20 Mar 2022

Understanding how coronavirus, RS virus and rhinovirus affect children

When Inger Heimdal started studying the coronavirus in children in 2014, not many people thought the topic sounded particularly exciting.

18 Mar 2022

SARS-CoV-2 Delta variant-induced antibody response largely focuses on class 1 and 2 antibody epitopes

A new study evaluated the specificity of antibody response elicited by the Delta variant of SARS-CoV-2.

18 Mar 2022

Neutrophils found to initiate COVID-19-associated olfactory epithelial damage in hamsters

Researchers evaluated the underlying cellular mechanisms of SARS-CoV-2-induced olfactory epithelium damage in golden Syrian hamsters.

18 Mar 2022

Innate and adaptive immune responses to BNT162b2 vaccination in mice

Researchers analyzed the innate and adaptive responses to the mRNA-based BNT162b2 COVID-19 vaccine in mice.

18 Mar 2022

Study explores SARS-CoV-2 spike epitope with potent and broad neutralization

Researchers reported an epitope with high potency and breadth and demonstrated that a therapeutic antibody directed at this site neutralizes all SARS-CoV-2 variants.

18 Mar 2022

immunity News and Research

Angiotensin-converting enzyme 2 allosteric binders found to be effective against SARS-CoV-2

Waning antibody responses in SARS-CoV-2-infected or vaccinated population

Study: Ketogenic diet helps kill pancreatic cancer cells when combined with a triple-drug therapy

New research proves benefit of vaccination after recovery from COVID-19

SARS-CoV-2 infection risk among dialysis patients during Omicron surge

Association between seropositivity and comorbidities after COVID-19 vaccination

Is COVID-19 on the verge of ending?

A circRNA COVID vaccine with potential to neutralize SARS-CoV-2 variants

SARS-CoV-2 transmitters have 3 times higher viral loads than non-transmitters

Mount Sinai launches phase 1 study to evaluate the safety, immunogenicity of egg-based COVID-19 vaccine

Oral drug that reverses immune aging effectively prevents death in COVID-19 mouse model

Glycogen synthase kinase-3 inhibitors found to attenuate COVID-19-associated cytokine storm

Clinical severity of SARS-CoV-2-Omicron infection found to be lower than Delta infection

Study assesses human milk antibodies against common human coronaviruses following COVID-19 infection and vaccination

Sex-specific differences in T-cell responses to COVID-19

Understanding how coronavirus, RS virus and rhinovirus affect children

SARS-CoV-2 Delta variant-induced antibody response largely focuses on class 1 and 2 antibody epitopes

Neutrophils found to initiate COVID-19-associated olfactory epithelial damage in hamsters

Innate and adaptive immune responses to BNT162b2 vaccination in mice

Study explores SARS-CoV-2 spike epitope with potent and broad neutralization

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News